Abstract:
Disclosed herein are cosmetic compositions comprising (1) at least one polyvinyl alcohol-styrylpyridinium polymer and (2) at least one latex film-forming polymer. Also disclosed herein are methods for making up and/or enhancing the appearance of a keratinous substrate comprising (1) forming a film on the keratinous substrate by applying to said keratinous substrate a cosmetic composition comprising (a) at least one polyvinyl alcohol-styrylpyridinium polymer and (2) at least one latex film-forming polymer and (2) exposing the film to radiation chosen from UV and visible light radiation.
Abstract:
Composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, at least one of mannose, and rhamnose and at least one additional compound chosen from C-glycosides and C-glycoside derivatives. Use of such a composition, and also a device containing it.
Abstract:
Stable, reduced whitening photoprotective compositions contain: a) at least one aqueous phase, b) at least hydrophilic metal oxide nanoparticles, and c) at least one vinylpyrrolidone homopolymer, formulated into d) a topically applicable, physiologically acceptable medium therefor.
Abstract:
The present invention relates to a composition, especially a cosmetic and/or dermatological composition, containing, in a physiologically acceptable medium, a combination of at least one monosaccharide chosen from mannose, rhamnose and a mixture thereof, and of at least one sunscreen. The present invention also relates to the use of such a composition.
Abstract:
Stable, recrystallization-resistant invert emulsions, suited, e.g., for preventing/treating the signs of chronological or actinic skin aging and for preventing/treating atrophy of the skin or mucous membranes, comprise a cosmetically/therapeutically effective amount of DHEA and/or chemical and/or biological precursor or derivative thereof, such invert emulsions also comprising a glycolic or hydroglycolic dispersed hydrophilic phase, a lipophilic continuous phase and an emulsifier having an HLB ranging from 2 to 7.
Abstract:
Individualized porous particles have a volume-average diameter of less than or equal to 10 μm and a specific surface area of greater than or equal to 1 m2/g, and include at least one cosmetically or pharmaceutically active compound present at least inside the particles.
Abstract:
The present invention relates to a composition which is in the form of a water-soluble anhydrous film comprising at least one water-soluble or water-dispersible film-forming polymer, and at least one live, in particular probiotic, microorganism. It also relates to a kit containing such a composition, as a combination with a secondary composition.
Abstract:
UV-Photoprotective oil-in-water emulsions well suited for photoprotecting the skin, lips and/or hair against the damaging effects of UV-radiation, the oil globules of which having an average size of at most 500 nm and containing particles of at least one ionic polymer and at least one UV-radiation-screening system, such screening system comprising at least one 4,4-diarylbutadiene UV-A-screening agent.
Abstract:
The invention relates to a composition containing an aqueous dispersion of colloidal particles of at least one mineral filler, and fibres. The invention also relates to a process for treating the skin, especially wrinkled skin, via the application of the described composition to the skin.
Abstract:
Novel double-stranded RNA oligonucleotides are useful for decreasing tyrosinase expression, have cosmetic and/or pharmaceutical applications, for example are useful skin depigmenting or anti-browning agents, and can be associated with cationic particles less than or equal to 1 μm in size, having a zeta potential of from 10 to 80 mV.